Grant: Operating Grant
McGill University
$324,676.00
Genomic medicine enters the clinic: translational research, actionable mutations, clinical utility, and the reframing of oncology
EF 2013-14
Résumé
The nature and scope of genomic initiatives in the cancer domain has expanded dramatically in recent years. A shift from the initial focus on diagnosis to the development of targeted therapies has given renewed meaning to notions such as personalized or precision medicine. The validation and testing of these therapies in clinical trials, their approval by regulators, and the necessary articulation of novel approaches with established clinical practices raise, however, a number of major organizational, regulatory, and sociotechnical issues, which in turn call for innovative solutions. These often-controversial solutions include the redesign of clinical trials and their organizational infrastructure, the mobilization of novel analytical platforms, and, in the end, a major reshaping of clinical and translational research. The purpose of our comparative (North America - Europe) project is to provide an analytical understanding of this complex dynamics, based on a detailed empirical investigation of the aforementioned initiatives, complemented by the use of network-analysis tools to closely follow and map developments and trends in the biomedical literature. In particular, we seek to analyze how fundamental changes in the social, organizational and conceptual configuration of biomedical practices are accompanied by the emergence of new collective modes of practice and interaction in the biomedical domain.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
290769
Name
Cambrosio Alberto
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Humanities, Social Sciences, Law & Ethics in Health
Projecttitle
Genomic medicine enters the clinic: translational research, actionable mutations, clinical utility, and the reframing of oncology
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$324,676
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Biomarkers; Biomedical Innovation; Cancer Genomics; Clinical Trials; Clinical Utility; Ethnographic Analysis; Network Analysis; Translational Research
Abstract
The nature and scope of genomic initiatives in the cancer domain has expanded dramatically in recent years. A shift from the initial focus on diagnosis to the development of targeted therapies has given renewed meaning to notions such as personalized or precision medicine. The validation and testing of these therapies in clinical trials, their approval by regulators, and the necessary articulation of novel approaches with established clinical practices raise, however, a number of major organizational, regulatory, and sociotechnical issues, which in turn call for innovative solutions. These often-controversial solutions include the redesign of clinical trials and their organizational infrastructure, the mobilization of novel analytical platforms, and, in the end, a major reshaping of clinical and translational research. The purpose of our comparative (North America - Europe) project is to provide an analytical understanding of this complex dynamics, based on a detailed empirical investigation of the aforementioned initiatives, complemented by the use of network-analysis tools to closely follow and map developments and trends in the biomedical literature. In particular, we seek to analyze how fundamental changes in the social, organizational and conceptual configuration of biomedical practices are accompanied by the emergence of new collective modes of practice and interaction in the biomedical domain.
Competitiondate
201309
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Cambrosio, Alberto; Keating, Peter
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $324,676~ $0~